Evolutionary regulation of human Fas ligand (CD95L) by plasmin in solid cancer immunotherapy

88

Evolutionary regulation of human Fas ligand (CD95L) by plasmin in solid cancer immunotherapy

Tags:

Previous Article

Immunotherapy for difficult-to-treat brain tumors with gut microbiota

Role of plasmin in metastatic tumors

Related Posts

Two translocation mechanisms drive neural stem cell dissemination into the human fetal cortex

Two translocation mechanisms drive neural stem cell dis...

34

Acetylated cellulose suppresses body mass gain through gut commensals consuming host- accessible carbohydrates

Acetylated cellulose suppresses body mass gain through...

130

RANK drives structured intestinal epithelial expansion during pregnancy

RANK drives structured intestinal epithelial expansion ...

105